Concepedia

Rebekah Watkins-Schulz

RW

4

Publications

490

Citations

4

H-Index

2017

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

North Carolina State University

Rebekah Watkins-Schulz is an author at University of North Carolina at Chapel Hill specializing in immunology, medicine, and t cell immunity.

Top concepts

MedicineImmunologyImmunotherapyTumor ImmunityT Cell ImmunityVaccinationAutoimmunityCell BiologyImmune SystemCell Signaling

Publications per year

2017–2022

4

Publications

4

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins et al. · JCI Insight · 2018 · 244 citations · Full text

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 147 citations

Vaccination, Mucosal Vaccination, Cross-protection +12

A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity

Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic et al. · Biomaterials · 2019 · 87 citations · Full text

Tumor Immunology, Sting-targeted Immunotherapy, Cancer Immunosurveillance +10

Microparticle Delivery of a STING Agonist Enables Indirect Activation of NK Cells by Antigen-Presenting Cells

Rebekah Watkins-Schulz, Cole J. Batty, Rebeca T. Stiepel et al. · Molecular Pharmaceutics · 2022 · 12 citations

Innate Immune System, Immunology, Immune Regulation +25

Rows per page

1–4 of 4